Our research focuses on the development of novel innovative technology for cancer therapeutics and diagnostics. We target cancer using small molecule drugs, protein-drug conjugates, bi-specific therapeutic proteins, and cell-based immunotherapies. We also work to develop novel platform technologies for isolating circulating tumour cells and cancer stem cells, as well as assays detecting urine-based biomarkers across multiple cancer indications. We have two main research programs: Urology Program and Pediatric Cancer Program